Article
Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 1 Aug 2012
Aziz Hafsa, Raza Abida, Waheed Yasir, Gill Uzma, Gill Muzaffar Lateef
Abstract excerpt
BACKGROUND: The recommended standard therapeutic regimen for chronic hepatitis patients with hepatitis C virus (HCV) genotype 3 is pegylated interferon plus ribavirin for 24 weeks. The aim of the present study was to evaluate treatment efficacy and variables predictive of treatment success, interactions among variables contributing to a response to therapy, and the utility of the rapid virological response (RVR;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.